Low Percentage of Free Prostate-specific Antigen (PSA) Is a Strong Predictor of Later Detection of Prostate Cancer Among Japanese Men With Serum Levels of Total PSA of 4.0 ng/mL or Less-Reference-Cited by-同舟云学术

Low Percentage of Free Prostate-specific Antigen (PSA) Is a Strong Predictor of Later Detection of Prostate Cancer Among Japanese Men With Serum Levels of Total PSA of 4.0 ng/mL or Less

Published:2014-11 Issue:5 Volume:84 Page:1163-1167
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Sasaki Mitsuharu^ORCID,Ishidoya Shigeto,Ito Akihiro,Saito Hideo^ORCID,Yamada Shigeyuki,Mitsuzuka Koji,Kaiho Yasuhiro,Shibuya Daisuke,Yamaguchi Takuhiro,Arai Yoichi

Publisher

Elsevier BV

Subject

Urology

Reference15 articles.

1. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen;Cooner;J Urol,1990

2. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med,1991

3. Prevalence of prostate cancer among men with a prostate-specific antigen level≤ 4.0 ng per milliliter;Thompson;N Engl J Med,2004

4. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study;Vickers;BMJ,2010

5. Men (aged 40-49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: results from a prospectively screened population cohort;Weight;Urology,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of PSA variability with prostate cancer development using large-scale medical information data: a retrospective cohort study;Genes and Environment;2023-10-17

2. Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml;Frontiers in Oncology;2022-07-28

3. A novel nomogram combined PIRADS v2 and neutrophil-to-lymphocyte ratio to predict the risk of clinically significant prostate cancer in men with PSA < 10 ng/ml at first biopsy;Urologic Oncology: Seminars and Original Investigations;2020-05

4. A surface-enhanced electrochemiluminescence sensor based on Au-SiO2 core–shell nanocomposites doped with Ru(bpy)32+ for the ultrasensitive detection of prostate-specific antigen in human serum;The Analyst;2020

5. NMR-Based Metabolomic Profiling of Urine: Evaluation for Application in Prostate Cancer Detection;Natural Product Communications;2019-05